UniProt ID | ANGE1_HUMAN | |
---|---|---|
UniProt AC | Q9UNK9 | |
Protein Name | Protein angel homolog 1 | |
Gene Name | ANGEL1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 670 | |
Subcellular Localization | ||
Protein Description | ||
Protein Sequence | MIASCLCYLLLPATRLFRALSDAFFTCRKNVLLANSSSPQVEGDFAMAPRGPEQEECEGLLQQWREEGLSQVLSTASEGPLIDKGLAQSSLALLMDNPGEENAASEDRWSSRQLSDLRAAENLDEPFPEMLGEEPLLEVEGVEGSMWAAIPMQSEPQYADCAALPVGALATEQWEEDPAVLAWSIAPEPVPQEEASIWPFEGLGQLQPPAVEIPYHEILWREWEDFSTQPDAQGLKAGDGPQFQFTLMSYNILAQDLMQQSSELYLHCHPDILNWNYRFVNLMQEFQHWDPDILCLQEVQEDHYWEQLEPSLRMMGFTCFYKRRTGCKTDGCAVCYKPTRFRLLCASPVEYFRPGLELLNRDNVGLVLLLQPLVPEGLGQVSVAPLCVANTHILYNPRRGDVKLAQMAILLAEVDKVARLSDGSHCPIILCGDLNSVPDSPLYNFIRDGELQYHGMPAWKVSGQEDFSHQLYQRKLQAPLWPSSLGITDCCQYVTSCHPKRSERRKYGRDFLLRFRFCSIACQRPVGLVLMEGVTDTKPERPAGWAESVLEEDASELEPAFSRTVGTIQHCLHLTSVYTHFLPQRGRPEVTTMPLGLGMTVDYIFFSAESCENGNRTDHRLYRDGTLKLLGRLSLLSEEILWAANGLPNPFCSSDHLCLLASFGMEVTAP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | S-palmitoylation | ---MIASCLCYLLLP ---CHHHHHHHHHHH | 1.94 | 29575903 | |
7 | S-palmitoylation | -MIASCLCYLLLPAT -CHHHHHHHHHHHHH | 2.36 | 29575903 | |
29 | Ubiquitination | DAFFTCRKNVLLANS HHHHHHHCCEEECCC | 54.26 | 21906983 | |
36 | Phosphorylation | KNVLLANSSSPQVEG CCEEECCCCCCCCCC | 26.96 | 26657352 | |
37 | Phosphorylation | NVLLANSSSPQVEGD CEEECCCCCCCCCCC | 45.93 | 30108239 | |
38 | Phosphorylation | VLLANSSSPQVEGDF EEECCCCCCCCCCCE | 21.12 | 25159151 | |
70 | Phosphorylation | QWREEGLSQVLSTAS HHHHHCHHHHHHHCC | 29.15 | 21712546 | |
77 | Phosphorylation | SQVLSTASEGPLIDK HHHHHHCCCCCCCCH | 43.08 | - | |
105 | Phosphorylation | PGEENAASEDRWSSR CCCCCCCCCCCCCHH | 37.30 | 28348404 | |
110 | Phosphorylation | AASEDRWSSRQLSDL CCCCCCCCHHHHHHH | 19.28 | 28348404 | |
111 | Phosphorylation | ASEDRWSSRQLSDLR CCCCCCCHHHHHHHH | 19.65 | 28348404 | |
115 | Phosphorylation | RWSSRQLSDLRAAEN CCCHHHHHHHHHHHC | 26.68 | 24719451 | |
318 | Phosphorylation | SLRMMGFTCFYKRRT HHHHCCCEEEEECCC | 8.93 | 46163179 | |
328 | Ubiquitination | YKRRTGCKTDGCAVC EECCCCCCCCCCEEE | 51.50 | - | |
336 | Phosphorylation | TDGCAVCYKPTRFRL CCCCEEEECCCCEEE | 17.26 | 11079431 | |
337 | Ubiquitination | DGCAVCYKPTRFRLL CCCEEEECCCCEEEE | 34.48 | - | |
347 | Phosphorylation | RFRLLCASPVEYFRP CEEEEECCCHHHHCC | 28.60 | 72500113 | |
351 | Phosphorylation | LCASPVEYFRPGLEL EECCCHHHHCCCHHH | 12.72 | 72500119 | |
416 | Ubiquitination | ILLAEVDKVARLSDG HHHHHHHHHHCCCCC | 42.86 | - | |
460 | Ubiquitination | YHGMPAWKVSGQEDF ECCCCCEEECCCCCC | 28.73 | - | |
472 | Phosphorylation | EDFSHQLYQRKLQAP CCCHHHHHHHHCCCC | 10.33 | 25159151 | |
475 | Ubiquitination | SHQLYQRKLQAPLWP HHHHHHHHCCCCCCC | 29.44 | - | |
591 | Phosphorylation | QRGRPEVTTMPLGLG CCCCCCCCCCCCCCC | 18.73 | 22210691 | |
592 | Phosphorylation | RGRPEVTTMPLGLGM CCCCCCCCCCCCCCC | 23.20 | 22210691 | |
622 | Phosphorylation | NRTDHRLYRDGTLKL CCCCCEEHHHHHHHH | 13.45 | 22817900 | |
628 | Ubiquitination | LYRDGTLKLLGRLSL EHHHHHHHHHHHHHH | 41.31 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ANGE1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ANGE1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ANGE1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of ANGE1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-347 AND TYR-351, ANDMASS SPECTROMETRY. |